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TREATMENT OF UNINHIBITED NEUROGENIC BLADDER
  DYSFUNCTION WITH ANTI－CHOLINERGIC AGENT
一EVALUATION OF THE EFFECT OF TIMEPIDIUM BROMIDE TO
  PATIENTS WITH UNINHIBITED NEUROGENIC BLADDER
  DYSFUNCTION BY THE ’URODYNAMIC EXAMINATIONS一
   Junnosuke FuKui， Kinya AsHiDA， Sadao OsHiKi
 Setsuo WATANABE， Yasuo AmA， Yutaka YANAGisAwA
Shunsuke UcHiyAMA， Tohru TAKEzAKi， Nobuhiko SHiBA
Takehisa YoNEyAMA， Yasunori ToMITA， Masahisa WAJiKi
     Kenji WATANABE and Katsuhiro HARADA
From the DePartment of Urolog2， Faculty of Medicine， Universit2 qf Shinshu
       ．Klyoshi KoDAiRA
From the Department of Urolog）， Okaya－citl HosPital
  Thirty patients with recurrent urinary tract infection or urinary incontinence were diagnosed
as refiex neurogenic bladder including uriinhibited neurogenic bladder or unstable bladder by a series
of tests including urological routine’ tests， roentgenograPhy （mainly， voiding cysto－urethrography），
urodynamic and electrophysiologic exarninations， urethral’pressure profile， and endoscopic examina－
tions， and by E E G and myelography for some cases． Some of them were．treated with timepidium
bromide， an anti－cholinergic agent， and the effects were evaluated by urodynamic examinations be－
fore and after the treatment． Other patients were sUbcutaneously injected with bethanecol chloride
and 30 minutes later subjected to urodynamic examinations． Then， they were intramuscularly in－
jected with timepidium bromide， and again subjected to urodynamic examination 30 minutes later．
88 福井・ほか：神経因性膀胱・薬物療法
The latter tirial／was an attempt to make vesical and urethral smooth inuscles more unstable and in
these conditions to probe the eMcacy of timepidium more clearly．
    The urodynamic examinations used in this series were Lewis’ cystometrogram for tbe bladder
filling phase’ and the voiding urodynamic examination （V V D） for the voiding phase with a 6 chan－
nel polygraph that simultaneously measured the vesical， urethral and intra－abdominal pressures，
tonus and E M G of the anql sphincter， and urinary flow rate．
    The subjects studied consisted of 6 males and 24 females from the age 6 to 65 （22 children and
8 adults）， and of 13 cases of unstable bladder and 17 cases of uninhibited neurogenic bladder．
    Timepidium bromide was very effective in 630／，， and only moderately effective in 200／， of the
treated patients． The effects of the drug were evaluated on the three voiding parameters， i． e． the
bladder volumcs at the丘rst desire to void，皿axirnal desire to void and maximal vcsical voiding pres－
sure before and after administration of the drug， and analyzed by Student “t” test to giv¢ the following
results； the first two parameters were greater with P〈O．OOI and the last Parameter smaller with O．Ol
＞P＞O．OO I after than before the treatment． This indi．cates that the vesical capacity increased and’
the voiding pressure decreased after the treatment with timepidium with high degrees of statistical
significance． ln other words， the lowered vesical capacity and the hypertonic condition in uninhi－
bited neurogenic bladder were ． alleviated by the treatment with timepidium．
    Compar三son of the urodynamic patterns on the 6 channeI polygraph between．pre－and post－ad－
ministration measurements revealed a decrease or complete disappeararice of the involuntary det－
rusor contractions during the filling phase after the drug treatment． lt was worthy of note that the
secondary spastic condition of the pelvic ・fioor musculature due to the involuntary contractions of
the detrusor decrcased or nearly．disappeared after the treatment．
    This iatter aspect seemed to be the one of the most important aptions in the mechanism for the
prevention of recurrent urinary tract infection and enuresis．
    The uroqynamic pattcrns during the voiding phasc indicated that the treatment with timcpi－
di・m d圭mini・h・d・r elimi・・t・d th・fi・rtu・ti・n・・f th・v・・i・4！．1・d th・μre重坤1．Prρr・u；・・．・b・erv・d be－
fore and after the’voiqing phase． lmprovement o£ dyssynergiq between detrus．or ．4nd ¢xternal urethral
sphincter was not clearly observed． ln conclusion， the treatment w；th anti－qholinergic agents svch
as timepidium should constitute the standard therqpy for uninhibited neurogep． ic bladder and un－
stable bladder， and． such an agent may be indicated in combinatioR with other drugs according to
symptoms． For example， the use of timepidium with tolperisone hydrochloride or diazepam should
be taken int6 consideration when the spasm of the pelvic floor musculature appears． Large doses
of an anti－cholinergic agent may be necessary for the uninhibited neurogenic bladder as a sequela
of cerebral infantile paralysis or other brain diseases’． ln these cases， combined medication with fla－
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 Tirncpidium bromideを静注，1時間後：IC bethanecol
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     定図（12・5kg雑種雌犬を使用）．
    A・Bethanecel ch1・ride静注後の各因子波形の変化，膀胱内圧の著明な圧の上昇と利尿筋・膀胱三角筋部位での電気的活動性0上昇が認められる．
    B．Timepidium bromide静注後の各因子波形の変化．本薬剤静注後に著明な膀胱内圧の一過性上昇後の低下が認められる．
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92               福井・ほか：神経因性膀胱・薬物療法
       Table 2．対象症例の年齢・主訴。測定方法・診断名および薬剤投与法の一覧表




































































  単 独 使 用




















































    約筋筋電図，尿流量率の同時測定の測定装置
















 Timepidium bromideおよびbethanecol chloride
の投与量はTable 3に示すごとき量を基準として投与
している。
Table 3． Timepidium BromideおよびBethanecol
     Chlorideの小児・成人の投与量
Timepidium（皮下注）  Bethanecol（皮下注）
つた（Table 2－B）．
重國姐）体 重  量（ml）
測 定 結 果
体
Io kg 0．15 10 kg O．15
15 kg O．25 15 kg O．2
20 kg O．3 20 kg O．3
25 kg 0．4 25 kg 0．35
30 kg 0．45 30 kg 0．45
35 kg 0．55 35 kg 0．5
40 kg O．6 4g kg O．55
45 kg 0．7 45 kg O．65
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Table 4－B． Timepidium Bromideの改善度
      判定基準
1． 自覚症状             ＋2
（灘、灘驕馨階・）Si
2．他覚的所見
  （Lewis， CystometrogramおよびVoidingurodynamic examinationより『）
 A． Lewis’ cystometrogram
  ・最大排尿圧：30mmHg↓＋3
         20 mmHg 」 十2





















    Mean l no．91 155・4
FDV  S。 D．  67．6． 81．5 Pく0．001
    S． E． j 14． 4 1 17L 3
    Mean l 222．0［ 301・8
MDV S・ D・ 129．9 160．5 PくQ，OO1












FDV： First Desire tQ Void
MDV： Maximal Desire to Void
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Fig．4． Unstable bladder例の1・cwB膀胱内圧測定図
    A．投与前の膀胱内圧波形
    B．Bethanecol投与後の膀胱内圧波形
    C．Timepidiun・投与後の膀胱内圧波形
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    O       瞬■NUT芭S      5      MINU了ES      10      岡INUTES      ¶5        0g nFig・5・無抑制型神経因性膀胱症例（小児）のLewis膀胱内圧測定図
    A．薬剤投与前の膀胱内圧波形
    B．Bcthanecol投与時の膀胱内圧波形
    C．Timepidium投与時の膀胱内圧波形
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Fig．6・混合型（自律型＋反射型）神経因性膀胱症例のLewis膀胱内圧測定図
     症例は遺尿を訴え来院した13歳の女児で潜在性脊椎破裂がある．現
     在tethered c・rd syndromeを疑い精査中の症例である．
    A・薬剤投与前Lewisの膀胱内圧測定図
    B．Bethanecol chloride投与後の膀胱内圧測定図
    G・TimePidium br。mide投与後の膀胱内圧測定図
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Fig・7・小児の無抑制膀胱症例のLewis cyst・metrogram（Timepidium br・midc内服）
    A・薬剤投与前の膀胱内圧波形．典型的な無抑制膀胱パターンを示す．
    B・Timepidium 90 mg／日内服後の膀胱内圧波形（約1ヵ月内服）
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 Fi9・9－i）3cha㎜el polygraphによる蓄尿期間中の膀胱内圧，肛門括約筋トーヌス，肛門括約筋
      EMGの同時測定図．
      A・Timepidi㎜投与前の波形．膀胱の無抑制収継こ一致した肛門括約筋トーヌスおよ
        びEMGでの収縮波形の出現を認める．
      B・Timepidiu・n投与後の波形．膀胱の無抑制収縮波形は軽減し，それに応じて肛門括
        約筋波形（トーヌスおよびEMGとも）も動揺が少なくなる．
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  本剤の投与後diStal segm㎝tでのUPP波形の圧低下が認められた．その他は変化
  ．を認められな唾このdistal segmentでの圧の低下は，抗コリン剤による利尿筋無
  抑制収縮の抑制された結果，骨盤床筋群の過緊張が抑制されたため生じたものとも
  解される．
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Fig．10．小児無抑制膀胱症例の6channei polygraphによる排尿因子同時測定波形（VUD波形）．
    A．抗コリン剤投与前のVUD波形
    B．抗コリン剤投与前のVUD波形
      Aに比べ膀胱圧，尿道圧波形が不安定であり，かつ骨盤床筋群の排尿期間中の収縮も
      認められた．尿道抵抗が大きいために，腹圧排尿をおこなっている．uninhibited type
      にはこのように排尿することに排尿パターンが異なることがよく認められる。
    C・抗コリン剤投与後のVUD波形
排尿が行なわれている．
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Fig。11・再発性尿路感染を有する無抑制型神経因性膀胱症例（小児）のVUD波形
    A・抗コリン剤（timepidium）投与前のVUD波形
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Fig．12． G． Flavoxate内月塞後のVUD波形
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    A．抗コリン剤投与前のVUD波形
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Fig．13・（】・Timepidium投与後のVUD波形
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